Top Markets
#1 Derive Derive +30.93%
#2 Audiera Audiera +14.63%
#3 Cross Cross +11.38%
#4 The Bitcoin Bull The Bitcoin Bull +10.74%
#5 Palladium Network Palladium Network +9.37%
#6 Gama Token Gama Token +9.19%
#7 Biconomy Biconomy +9.00%
#8 Humanity Humanity +8.26%
#9 Geodnet Geodnet +7.98%
#10 Velvet Velvet +7.50%
Coin of the day
Derive Derive
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Rang in aandelen #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Aandeelprijs
$0.46
Laatst gesynchroniseerd: 2026-07-31
Marktkapitalisatie
$3.42M
Verandering (1 dag)
3.60%
Verandering (1 jaar)
-34.54%
Land
US
Handel Pasithea Therapeutics Corp. (KTTA)

Categorie

Healthcare
Koersgeschiedenis voor Pasithea Therapeutics Corp. (KTTA)
Hoogste slotkoers: $0.48 op 2026-07-01

Laagste slotkoers: $60.62 op 2021-09-01
Koersgeschiedenis van Pasithea Therapeutics Corp. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -33.96%
2025 -58.48%
2024 -61.05%
2023 -55.07%
2022 -63.23%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE